Outpatient Oncology Infusion Market Trending Technologies, Development Plans, Future Growth and Geographical Regions to 2030

The MarketWatch News Department was not involved in the creation of this content.

Jun 20, 2022 (Market Insight Reports) — Selbyville, Delaware: A substantial rise in advancements in cancer treatment procedures, tools, and options is envisaged to support prolific expansion of the global outpatient oncology infusion market share over 2022-2030. Not to mention, increasing cases of cancer would add considerably to the demand for the procedure in the coming years.

For the record, cancer is the second leading cause of deaths worldwide. In fact, according to an estimation by Cancer.org, the number of new cancer cases and fatalities in the United States is projected to be 1.9 million new cases and about 609,390 deaths.

To access a sample copy or view the Outpatient Oncology Infusion Market report in detail along with the table of contents, please click the link below:https://www.gminsights.com/request-sample/detail/5268

Introduction to several initiatives that seek to extend awareness regarding the different types of cancer amongst masses is also likely to stimulate the market dynamics to a much greater extent. In 2021, the World Health Organization, in partnership with other UN agencies and partner organizations launched the Global Breast Cancer Initiative. Through this initiative, the agency seeks to reduce the global burden of breast cancer by 2.5% annually until 2050. In addition, it would also offer guidance to governments on strengthening systems for treating and diagnosing breast cancer.

Indeed, the outpatient oncology infusion market is poised to account for USD 162.4 billion by 2030 end, with the demand for the same escalating in different cancer treatments.

  1. Breast cancer

Consider the following pointers:

  • In 2021, breast cancer was one of the most common cancers worldwide accounting for 12% of all new yearly cancer cases.
  • org speculates 2022 to record 287,850 new cases of invasive breast cancer cases.

With the incidences of breast cancer just elevating, different treatment therapies are making way complementing the oncology infusion market share. Chemotherapy infusion is one of these treatments. It delivers medication directly into the bloodstream to fight cancer.

Crucial advantages associated with chemotherapy infusion for breast cancer include decreasing the risk of cancer revival, increasing the chances of a cure, reducing symptoms from cancer, and helping people with cancer live a longer and stable life.

  1. Lung cancer

Outpatient oncology infusion is gaining widespread acclamation in the treatment of lung cancers. Growth in the cases of lung cancer globally is reported to have a positive impact on the treatment statistics. As per Cancer.org, 2020 recorded about 236,740 new cases of lung cancer and nearly 130,180 fatalities from the disease.

This has put forth the need for effective outpatient oncology infusion treatment. One of the potential solutions is targeted therapy. These are medications that restrict certain molecules that impact the cancer’s ability to spread. Targeted therapies for lung cancer are often the therapy of choice for patients with advanced stage non-small cell lung cancer that accounts for nearly 84% of all lung cancer analysis.

The targeted therapy space for lung cancer is rapidly evolving with the changing pace of scientific research and developments. To illustrate, in 2021, the US FDA offered a green signal to Lumakras as the first line of treatment for adult patients with NSCLC. It is considered to be the first approved targeted therapy for tumors with any KRAS mutation.

  1. Prostate cancer

With about 1 in 8 men being diagnosed with prostate cancer during the entire lifetime, the ailment is anticipated to emerge as a critical vertical in the outpatient oncology infusion industry. The prostrate cancer segment in the industry had secured a market share of $7.3 billion in 2021 and is now eyeing for lucrative growth and opportunities in the coming years.

Currently, immunotherapies are one of the ideal therapeutic options for prostate cancer. The treatment for prostate cancer is a promising area of research for metastatic cancer treatment and involved 3 FDA-approved treatment options including Sipuleucel-T, Pembrolizumab, and Dostarlimab.

With sedentary lifestyle, unhealthy eating habits, alcohol consumption, and smoking rates continuing to escalate worldwide, the chances of cancer cases increasing are positive. This would require introduction to effective treatment options that could, to some extent, alleviate the incidences. This would support a prolific expansion of the outpatient oncology infusion market in the years ahead.

Partial Table of Contents (ToC) of the Outpatient Oncology Infusion Market report:

Chapter 4 Outpatient Oncology Infusion Market, By Product

4.1 Key segment trends

4.2 Infusion Pumps

4.2.1 Market size, by region, 2017 – 2030 (USD Million)

4.3 Intravenous Sets

4.3.1 Market size, by region, 2017 – 2030 (USD Million)

4.4 IV Cannulas

4.4.1 Market size, by region, 2017 – 2030 (USD Million)

4.5 Needleless Connectors

4.5.1 Market size, by region, 2017 – 2030 (USD Million)

Chapter 5 Outpatient Oncology Infusion Market, By Application

5.1 Key segment trends

5.2 Lung Cancer

5.2.1 Market size, by region, 2017 – 2030 (USD Million)

5.3 Liver Cancer

5.3.1 Market size, by region, 2017 – 2030 (USD Million)

5.4 Breast Cancer

5.4.1 Market size, by region, 2017 – 2030 (USD Million)

5.5 Prostate Cancer

5.5.1 Market size, by region, 2017 – 2030 (USD Million)

5.6 Other

5.6.1 Market size, by region, 2017 – 2030 (USD Million)

Browse complete table of content of this report @ https://www.gminsights.com/toc/detail/outpatient-oncology-infusion-market

About Global Market Insights

Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.


Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.